Last edition
News about " U.S. respiratory drug manufacturing facility in F"
Lupin to Invest USD 250 Million in New USA Respiratory Drug Manufacturing Facility in Florida
Lupin has announced plans to invest USD 250 million over the next five years to establish a new state-of-the-art manufacturing facility in Coral Springs, Florida. The facility will focus on producing over 25 essential respiratory medicines, including albuterol inhalers.
U.S. Respiratory Drug Manufacturing Facility In F | 09/10/2025 | By Darshana | 109
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members